(Q35748459)

English

Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results

scientific article published on 7 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

10

object named as

R Storb

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Steven Z. Pavletic

8

object named as

S Z Pavletic

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

author name string

J D Bowen

1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

G H Kraft

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

A Wundes

3

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Q Guan

4

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

K R Maravilla

5

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

T A Gooley

6

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

P A McSweeney

7

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

H Openshaw

9

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

M Wener

11

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

B A McLaughlin

12

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

G R Henstorf

13

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

R A Nash

14

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

language of work or name

0 references

publication date

7 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

946-951

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Autologous hematopoietic cell transplantation for multiple sclerosis: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

12 July 2018

The challenge of follow-on biologics for treatment of multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

12 July 2018

The relation between inflammation and neurodegeneration in multiple sclerosis brains.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

12 July 2018

Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

12 July 2018

Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

12 July 2018

Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

12 July 2018

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

12 July 2018

Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

12 July 2018

Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

12 July 2018

Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

12 July 2018

Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

12 July 2018

Stem cell transplantation for multiple sclerosis: What is the evidence?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

12 July 2018

Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

12 July 2018

High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

12 July 2018

CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

12 July 2018

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

12 July 2018

Acute/relapsing experimental autoimmune encephalomyelitis: induction of long lasting, antigen-specific tolerance by syngeneic bone marrow transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

12 July 2018

Assessment of brain changes with registered MR before and after bone marrow transplantation for chronic myeloid leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

12 July 2018

Defining the clinical course of multiple sclerosis: Results of an international survey

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

12 July 2018

https://api.crossref.org/works/10.1038%2FBMT.2011.208

21 January 2018

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

12 July 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

12 July 2018

High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

25 September 2018

Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

25 September 2018

High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

25 September 2018

Bone-marrow transplantation fails to halt intrathecal lymphocyte activation in multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

25 September 2018

The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

25 September 2018

Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

25 September 2018

Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

25 September 2018

Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

25 September 2018

Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

25 September 2018

Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276694

25 September 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.208

21 January 2018

Long-term results of stem cell transplantation for MS: A single-center experience

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.208

21 January 2018

Autologous hematopoietic stem cell transplantation for very active relapsing-remitting multiple sclerosis: report of two cases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.208

21 January 2018

Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22056644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous peripheral blood stem cell transplantation for severe multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22056644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database

1 reference

https://pubmed.ncbi.nlm.nih.gov/22056644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22056644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22056644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conditioning regimens for the treatment of experimental arthritis with autologous bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22056644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores

1 reference

https://pubmed.ncbi.nlm.nih.gov/22056644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system

1 reference

https://pubmed.ncbi.nlm.nih.gov/22056644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BMT.2011.208

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35748459&oldid=2197681664"